Along these lines, pathologies such as Alzheimer's disease [71,72], Parkinson's disease [73,74] and amyotrophic lateral sclerosis [75] show increased astrogliosis reactivity with a consequent up-regulation of GFAP levels. This evidence concerns the gene GFAP and early-onset autosomal dominant Alzheimer disease.